SCHEMBL19567667

SCHEMBL19567667

N#CC[C@]1(I)CC[C@H](NCc2cccc(F)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CARM1 Q86X55 2/20 0.47
▸ PRMT6 Q96LA8 2/20 0.47
▸ JAK2 O60674 6/20 0.46
▸ JAK1 P23458 6/20 0.46
▸ KDM1A O60341 2/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ HRH2 P25021 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.38
▸ OPRM1 P35372 2/20 0.37
▸ OPRL1 P41146 2/20 0.37
▸ ATM Q13315 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CCR3 P51677 1/20 0.37
▸ CCNT1 O60563 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19567519 0.85 CARM1 (0.50) CARM1PRMT6JAK2JAK1KDM1A
SCHEMBL19567412 0.85 CARM1 (0.50) CARM1PRMT6JAK2JAK1KDM1A
SCHEMBL23514508 0.85 CARM1 (0.50) CARM1PRMT6JAK2JAK1KDM1A
SCHEMBL19567376 0.83 CARM1 (0.48) CARM1PRMT6JAK2JAK1KDM1A
SCHEMBL19567521 0.82 CARM1 (0.47) CARM1PRMT6JAK2JAK1KDM1A
SCHEMBL2732150 0.78 CARM1 (0.63) CARM1PRMT6KDM1AMAOAMAOB
SCHEMBL24093079 0.77 CARM1 (0.51) CARM1PRMT6JAK2JAK1KDM1A
SCHEMBL19567373 0.77 CARM1 (0.51) CARM1PRMT6JAK2JAK1KDM1A
SCHEMBL19567514 0.77 CARM1 (0.51) CARM1PRMT6JAK2JAK1KDM1A
Hydrochloric Acid SCHEMBL4879048 0.77 CARM1 (0.62) CARM1PRMT6KDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452464-B1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF HOFFMANN LA ROCHE (CH) 2021-12-15 — — EP disclosed
WO-2017191098-A1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-11-09 — — WO disclosed
Send feedback